Propranolol for infantile haemangiomas: certain chances, potential risks

scientific article published on 01 January 2015

Propranolol for infantile haemangiomas: certain chances, potential risks is …
instance of (P31):
scholarly articleQ13442814
editorialQ871232

External links are
P356DOI10.1111/BJD.13535
P698PubMed publication ID25581581

P50authorPeter H. HoegerQ43058222
P433issue1
P304page(s)3-4
P577publication date2015-01-01
P1433published inBritish Journal of DermatologyQ4970191
P1476titlePropranolol for infantile haemangiomas: certain chances, potential risks
P478volume172

Reverse relations

cites work (P2860)
Q55266898Effects of Propranolol on Neurodevelopmental Outcomes in Patients with Infantile Hemangioma: A Case-Control Study.
Q49012688Phytochemical Inhibition of Multidrug Resistance Protein-1 as a Therapeutic Strategy for Hemangioendothelioma
Q60949875Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas
Q35645474Treatment of infantile haemangiomas: recommendations of a European expert group

Search more.